Viewing Study NCT05745857


Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2025-12-25 @ 4:05 PM
Study NCT ID: NCT05745857
Status: UNKNOWN
Last Update Posted: 2023-02-27
First Post: 2023-02-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Sponsor: University Medical Center Groningen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module